Teva said that it is working to finalize a comprehensive specialty pharmacy support program which will help facilitate successful home administration of Synribo for HCPs, their patients and caregivers. This program is expected to begin early in the second quarter of 2014.
Teva Oncology VP and general manager Bill Campbell said, “Home administration can reduce the number of required doctor office visits for patients being treated with Synribo, while still maintaining close collaboration with their healthcare provider to manage their treatment regimen.”
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments